Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel approaches to tuberculosis vaccine development.

Literature DB >> 27816661

Novel approaches to tuberculosis vaccine development.

Stefan H E Kaufmann¹, January Weiner², C Fordham von Reyn³.

Abstract

Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette-Guérin (BCG) vaccine offers only limited protection against TB. New vaccine candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as live mycobacterial vaccines. Current developments in TB vaccines are summarized in this review.

Entities: Disease

Keywords: Post-exposure vaccine; Pre-exposure vaccine; Preventive vaccine; Subunit vaccine; Therapeutic vaccine; Whole-cell vaccine

Mesh：

Substances：

Year: 2016 PMID： 27816661 DOI： 10.1016/j.ijid.2016.10.018

Source DB: PubMed Journal: Int J Infect Dis ISSN： 1201-9712 Impact factor: 3.623

Keyword Cloud
Cited

50 in total

1. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

Authors: Cesar Boggiano; Katrin Eichelberg; Lakshmi Ramachandra; Jaqueline Shea; Lalita Ramakrishnan; Samuel Behar; Joel D Ernst; Steven A Porcelli; Markus Maeurer; Hardy Kornfeld
Journal: Vaccine Date: 2017-05-02 Impact factor: 3.641

2. Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Authors: Lázaro Moreira Marques Neto; Nicholas Zufelato; Ailton Antônio de Sousa-Júnior; Monalisa Martins Trentini; Adeliane Castro da Costa; Andris Figueiroa Bakuzis; André Kipnis; Ana Paula Junqueira-Kipnis
Journal: Hum Vaccin Immunother Date: 2018-07-12 Impact factor: 3.452

Review 3. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors: Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal: J Clin Invest Date: 2020-06-01 Impact factor: 14.808

4. Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings.

Authors: Marissa Renardy; Denise E Kirschner
Journal: J Theor Biol Date: 2019-03-06 Impact factor: 2.691

5. Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation.

Authors: Sam Afkhami; Rocky Lai; Michael R D'agostino; Maryam Vaseghi-Shanjani; Anna Zganiacz; Yushi Yao; Mangalakumari Jeyanathan; Zhou Xing
Journal: J Infect Dis Date: 2019-09-13 Impact factor: 5.226

6. BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.

Authors: Srabanti Rakshit; Asma Ahmed; Vasista Adiga; Bharath K Sundararaj; Pravat Nalini Sahoo; John Kenneth; George D'Souza; Wesley Bonam; Christina Johnson; Kees Lmc Franken; Tom Hm Ottenhoff; Greg Finak; Raphael Gottardo; Kenneth D Stuart; Stephen C De Rosa; M Juliana McElrath; Annapurna Vyakarnam
Journal: JCI Insight Date: 2019-12-19

Novel approaches to tuberculosis vaccine development.

1. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.

2. Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Review 3. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

4. Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settings.

5. Single-Dose Mucosal Immunotherapy With Chimpanzee Adenovirus-Based Vaccine Accelerates Tuberculosis Disease Control and Limits Its Rebound After Antibiotic Cessation.

6. BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.

Review 7. Undernutrition and Tuberculosis: Public Health Implications.

8. Synthesis and immunogenicity of the Mycobacterium tuberculosis arabinomannan-CRM197 conjugate.

Review 9. The current status, challenges, and future developments of new tuberculosis vaccines.

10. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.